New: Clinical trial search, funded by the National Cancer Institute
New: NCI-funded clinical trial search
Community
Tools
Company
Support
Sign in
Join for Free
Join for Free
Community
When would you consider immunotherapy in the treatment of patients with metastatic SMARCA4 (BRG deficient) carcinoma?
Recent case reports have shown its activity in this rare entity.
Good Question
Save
Request Answers
Share
Add Answer
